I was listening to Buterin on the Tim Ferriss podcast this morning, he made an offhand comment that biotech is at a similar point that computers were in the 50s; that left it salient with I read this, but in conversation and from general reading I have a sense that there’s a good chance that a lot of progress is about to be unlocked in the field due to machine learning, much cheaper / higher throughput genetic sequencing and DNA/RNA/protein synthesis and much better DNA editing techniques due to CRISPR.
IBM managed to extract some value from the computer revolution but the real gains where made by countries that were founded later.
Big Pharma companies at the moment seem more disfunctional then IBM back (there’s a reason why DeepMind does protein folding prediction and Pfizer doesn’t), so I would expect a good portion of the profits to be made by new biotech companies.
As far as biotech and Buterin, VitaDAO is currently in formation. Longevity biotech DAO on the blockchain hits a lot of hip keywords.
I was listening to Buterin on the Tim Ferriss podcast this morning, he made an offhand comment that biotech is at a similar point that computers were in the 50s; that left it salient with I read this, but in conversation and from general reading I have a sense that there’s a good chance that a lot of progress is about to be unlocked in the field due to machine learning, much cheaper / higher throughput genetic sequencing and DNA/RNA/protein synthesis and much better DNA editing techniques due to CRISPR.
IBM managed to extract some value from the computer revolution but the real gains where made by countries that were founded later.
Big Pharma companies at the moment seem more disfunctional then IBM back (there’s a reason why DeepMind does protein folding prediction and Pfizer doesn’t), so I would expect a good portion of the profits to be made by new biotech companies.
As far as biotech and Buterin, VitaDAO is currently in formation. Longevity biotech DAO on the blockchain hits a lot of hip keywords.